171 related articles for article (PubMed ID: 29982185)
21. Radium 223: how can we optimize this new tool for metastatic castration-resistant prostate cancer?
Dorff TB; Gross ME
Am Soc Clin Oncol Educ Book; 2015; ():e270-3. PubMed ID: 25993185
[TBL] [Abstract][Full Text] [Related]
22. Updates on radium-223 for castration-resistant prostate cancer presented at the Genitourinary Cancers Symposium, January 7-9, 2016, San Francisco, California.
Barkin J
Can J Urol; 2016 Jun; 23(3):8306-7. PubMed ID: 27347626
[No Abstract] [Full Text] [Related]
23. Radium-223 and concomitant therapies in patients with metastatic castration-resistant prostate cancer: an international, early access, open-label, single-arm phase 3b trial.
Saad F; Carles J; Gillessen S; Heidenreich A; Heinrich D; Gratt J; Lévy J; Miller K; Nilsson S; Petrenciuc O; Tucci M; Wirth M; Federhofer J; O'Sullivan JM;
Lancet Oncol; 2016 Sep; 17(9):1306-16. PubMed ID: 27473888
[TBL] [Abstract][Full Text] [Related]
24. A RANKL Wrinkle: Denosumab-Induced Hypocalcemia.
Laskowski LK; Goldfarb DS; Howland MA; Kavcsak K; Lugassy DM; Smith SW
J Med Toxicol; 2016 Sep; 12(3):305-8. PubMed ID: 26987988
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer - Therapy with radium-223.
Brito AE; Amorim BJ; Martello M; Bernardo WM; Etchebehere E;
Rev Assoc Med Bras (1992); 2017 Dec; 63(12):1019-1023. PubMed ID: 29489974
[No Abstract] [Full Text] [Related]
26. The Mode-of-Action of Targeted Alpha Therapy Radium-223 as an Enabler for Novel Combinations to Treat Patients with Bone Metastasis.
Suominen MI; Wilson T; Käkönen SM; Scholz A
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31405099
[TBL] [Abstract][Full Text] [Related]
27. Prostate cancer, version 1.2014.
Mohler JL; Kantoff PW; Armstrong AJ; Bahnson RR; Cohen M; D'Amico AV; Eastham JA; Enke CA; Farrington TA; Higano CS; Horwitz EM; Kawachi MH; Kuettel M; Lee RJ; Macvicar GR; Malcolm AW; Miller D; Plimack ER; Pow-Sang JM; Richey S; Roach M; Rohren E; Rosenfeld S; Small EJ; Srinivas S; Stein C; Strope SA; Tward J; Walsh PC; Shead DA; Ho M;
J Natl Compr Canc Netw; 2013 Dec; 11(12):1471-9. PubMed ID: 24335682
[TBL] [Abstract][Full Text] [Related]
28. Updated:
Boni G; Monari F
Tumori; 2019 Jun; 105(3):271. PubMed ID: 30866748
[No Abstract] [Full Text] [Related]
29. A Retrospective Analysis of the First 41 mCRPC Patients with Bone Pain Treated with Radium-223 at the National Institute of Oncology in Hungary.
Küronya Z; Sinkovics I; Ágoston P; Bíró K; Bodrogi I; Böde I; Dank M; Gyergyay F; Vajdics T; Kolonics Z; Nagyiványi K; Rúzsa Á; Géczi L
Pathol Oncol Res; 2017 Oct; 23(4):777-783. PubMed ID: 28074331
[TBL] [Abstract][Full Text] [Related]
30. Hypocalcaemia following thyroidectomy unresponsive to oral therapy.
Etheridge ZC; Schofield C; Prinsloo PJ; Sturrock ND
Hormones (Athens); 2014; 13(2):286-9. PubMed ID: 24776629
[TBL] [Abstract][Full Text] [Related]
31. Hungry bone syndrome: persistent hypocalcemia related to osteoblastic bone metastases of prostate cancer.
Riveros HA; Almodóvar LO; Danés CF; Domingo JP
J Palliat Med; 2013 Dec; 16(12):1496-7. PubMed ID: 24160743
[No Abstract] [Full Text] [Related]
32. [Radium-223 for the treatment of bone metastasis of prostate cancer].
Xu XF; Wei ZF; Zhang ZY
Zhonghua Nan Ke Xue; 2017 Jan; 23(1):78-81. PubMed ID: 29658243
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Prostate Cancer and the Bone: Significance and Therapeutic Options.
Gartrell BA; Coleman R; Efstathiou E; Fizazi K; Logothetis CJ; Smith MR; Sonpavde G; Sartor O; Saad F
Eur Urol; 2015 Nov; 68(5):850-8. PubMed ID: 26153564
[TBL] [Abstract][Full Text] [Related]
34. [Bone-targeted treatment in prostate cancer].
Géczi L; Sinkovics I
Magy Onkol; 2014 Sep; 58(3):199-203. PubMed ID: 25260084
[TBL] [Abstract][Full Text] [Related]
35. Three-year follow-up of a phase II study of radium-223 dichloride in Japanese patients with symptomatic castration-resistant prostate cancer and bone metastases.
Uemura H; Uemura H; Nagamori S; Wakumoto Y; Kimura G; Kikukawa H; Yokomizo A; Mizokami A; Kosaka T; Masumori N; Kawasaki Y; Yonese J; Nasu Y; Fukasawa S; Sugiyama T; Kinuya S; Hosono M; Yamaguchi I; Akagawa T; Matsubara N
Int J Clin Oncol; 2019 May; 24(5):557-566. PubMed ID: 30875000
[TBL] [Abstract][Full Text] [Related]
36. Metabolism and pharmacokinetics of radium-223 in prostate cancer.
Yeku O; Slovin SF
Expert Opin Drug Metab Toxicol; 2015 May; 11(5):843-9. PubMed ID: 25740232
[TBL] [Abstract][Full Text] [Related]
37. Could the efficacy of docetaxel in prostate cancer patients be potentiated by concomitant high-dose calcitriol administration?
Berruti A; Tucci M; Mosca A; Ardine M; Poggio M; Saini A; Russo L; Vana F; Dogliotti L
J Clin Oncol; 2008 Apr; 26(11):1900-1; author reply 1901-2. PubMed ID: 18398157
[No Abstract] [Full Text] [Related]
38. [Encounter of cancer cells with bone. Management of bone metastasis arising from prostate cancer].
Kamoto T
Clin Calcium; 2011 Mar; 21(3):465-71. PubMed ID: 21358069
[TBL] [Abstract][Full Text] [Related]
39. The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease.
Turner CJ; Edwards CM
Curr Osteoporos Rep; 2016 Oct; 14(5):170-7. PubMed ID: 27566487
[TBL] [Abstract][Full Text] [Related]
40. Abiraterone and increased survival in metastatic prostate cancer.
Parker C; Sartor O
N Engl J Med; 2011 Aug; 365(8):767. PubMed ID: 21864180
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
